All HEI'sAthlone Institute of TechnologyCork Institute of TechnologyDublin City UniversityDublin Institute of TechnologyMaynooth UniversityNational University of Ireland, GalwayRoyal College of SurgeonsTeagascTrinity College DublinUniversity College CorkUniversity College DublinUniversity of LimerickWaterford Institute of Technology All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsAutoCASM – Compressed Air Systems Metrics: Licensing Opportunity from Trinity College Dublin - August 2015Auto-CASM Compressed Air Systems Metrics is a technology comprising a suite of hardware and software tools optimised for monitoring the operating parameters and energy consumption of Compressed Air Systems and Processes.... pdf 709.1KBAntimicrobial Nanoparticles: Licensing Opportunity from Trinity College Dublin - August 2015Control of microbial growth and contamination is vital in every aspect of human life and also in many manufacturing sectors. We have developed new antibacterial nanoparticulate coatings which have much higher efficiency ... pdf 730.1KBBeer Spoilage Prevention – Using natural antimicrobial peptides: Licensing Opportunity from Trinity College Dublin - July 2015Using natural antimicrobial peptides; The innovative aspect of the technology utilises antimicrobial compounds that could reduce or eliminate bacterial contamination during the fermentation process. Pilot-scale fermentat... pdf 863.7KBVIPER: a virally-derived peptide that blocks inflammation: Licensing Opportunity from Trinity College Dublin - July 2015Over millennia, viruses have optimised their ability to inhibit the immune response. Thus the Vaccinia virus protein A46 displays a remarkable ability to inhibit TLR4 function. We have exploited this viral know-how and d... pdf 1.1MBMucosal Vaccines: Using a novel targeting molecule to create effective mucosal vaccines, Licensing Opportunity from Trinity College Dublin - July 2015Mucosal Vaccines – Using a novel targeting molecule to create effective mucosal vaccines; Our novel mimetic of the lectin Ulex europaeus agglutinin-1 from the gorse bush, provides a means to develop effective mucosal vac... pdf 927.3KB First 12345678910111213141516171819202122232425 Last Print Bookmark Top